One frequent medication used to prevent nausea and vomiting related to some types of chemotherapy is called APREVIT. This is especially useful in cases where the chemotherapy treatments have a high risk of causing these side effects. It is a member of the pharmacological class known as antagonists of neurokinin-1 receptors. APREVIT is offered as a capsule. APREVIT capsules typically come in dosages of 40 mg for a one-dose regimen and 125 mg for a three-day regimen. The particular chemotherapy regimen and the advice of the healthcare practitioner determine the recommended dosage and course of treatment. It is usually recommended to patients to take APREVIT as prescribed by their physician, frequently in conjunction with other anti-nausea drugs. Prior to the commencement of chemotherapy, the first dose is often administered, and additional doses may be taken on subsequent